Walleye Trading LLC Ascendis Pharma A/S Transaction History
Walleye Trading LLC
- $52.6 Billion
- Q2 2025
A detailed history of Walleye Trading LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Walleye Trading LLC holds 2,605 shares of ASND stock, worth $525,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,605
Previous 32,000
91.86%
Holding current value
$525,168
Previous $4.99 Million
91.0%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ASND
# of Institutions
285Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.07 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.1 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$1 Billion15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$893 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$858 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.3B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...